Amarin Corp. Plc (AMRN)
15.63
-0.09
(-0.59%)
USD |
NASDAQ |
Feb 20, 16:00
15.59
-0.04
(-0.24%)
After-Hours: 20:00
Amarin SG&A Expense (Quarterly) : 17.83M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Trinity Biotech Plc | 6.429M |
| Alkermes Plc | 171.77M |
| Jazz Pharmaceuticals Plc | 530.65M |
| Biodexa Pharmaceuticals Plc | -- |
| Evaxion AS | 0.00 |